Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: The CAMUNI-MATISS Cohorts Collaboration Study

European Journal of Preventive Cardiology

Volumn 22, Issue 12, 2015, Pages 1618-1625

  Veronesi, Giovanni ^a   Gianfagna, Francesco ^a   Giampaoli, Simona ^b   Chambless, Lloyd E ^c   Grassi, Guido ^d,e   Cesana, Giancarlo ^d   Ferrario, Marco M ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

calibration; Cardiovascular disease; clinical utility; discrimination; Italy; prediction model; primary prevention; validity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MONITORING UNIT IN NORTHERN ITALY RISK SCORE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; SMOKE; SYSTOLIC BLOOD PRESSURE; AGED; AREA UNDER THE CURVE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; HEALTH STATUS INDICATOR; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PRIMARY PREVENTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; VALIDATION STUDY;

ADULT; AGED; AREA UNDER CURVE; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY PREVENTION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84947439397     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314563709     Document Type: Article

References (33)

1. Grover SA, Lowensteyn I,. The challenges and benefits of cardiovascular risk assessment in clinical practice. Can Journal Cardiol 2011; 27: 481-487.
2. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-798.
3. Di Castelnuovo A, Costanzo S, Persichillo M, et al. Distribution of short and lifetime risks for cardiovascular disease in Italians. Eur J Prev Cardiol 2011; 19: 723-730.
4. Pencina MJ, D'Agostino RB, Larson MG, et al. Predicting the 30-year risk of cardiovascular disease. The Framingham Heart Study. Circulation 2009; 119: 3078-3084.
5. Cox JH, Coupland C, Robson J, et al. Derivation, validation and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular diseases: Cohort study using QResearch database. Br Med J 2010; 341: c6624-c6624.
6. Ferrario M, Chiodini P, Chambless LE, et al. for the CUORE Project Research Group. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413-421.
7. Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J 2007; 153: 722-731.
8. Allan GM, Nouri F, Koronwnyk C, et al. Agreement among cardiovascular disease risk calculators. Circulation 2013; 127: 1948-1956.
9. Veronesi G, Gianfagna F, Chambless LE, et al. Long-term prediction of major coronary or ischemic stroke event in a low-incidence Southern European population: Model development and evaluation of clinical utility. BMJ Open 2013; 3: e003630-e003630.
10. Veronesi G, Gianfagna F, Giampaoli S, et al. Improving long-term prediction of first cardiovascular event: The contribution of family history of coronary heart disease and social status. Prev Med 2014; 64: 75-80.
11. Harrel FE, Lee KL, Marck DB,. Tutorial in biostatistics: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med 1996; 15: 361-387.
12. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 2014; 63: 2935-2959.
13. Zomer E, Liew D, Owen A, et al. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms. Eur J Prev Cardiol 2014; 21: 384-390.
14. Ferrario M, Sega R, Chatenoud L, et al. Time trends of major coronary risk factors in a northern Italian population (1986-1994). How remarkable are socio-economic differences in an industrialised low CHD incidence country? Int J Epidemiol 2001; 30: 285-291.
15. Cesana GC, De Vito G, Ferrario M, et al. Ambulatory blood pressure normalcy: The PAMELA study. J Hypertension Suppl 1991; 9: 17-23.
16. Giampaoli S, Poce A, Sciarra F, et al. Change in cardiovascular risk factors during a 10-year community intervention program. Acta Cardiologica 1997; 5: 372-379.
17. WHO MONICA Project. MONICA Manual, http://www.thl.fi/publications/monica/manual/index.htm (1998-1999) (accessed 10 July 2014).
18. Steyerberg EW,. Clinical prediction models, New York: Springer Science + Business Media, LLC, 2009.
19. Chambless LE, Cummiskey CP, Cui G,. Several methods to assess improvement in risk prediction models: Extension to survival analysis. Statist Med 2011; 30: 22-28.
20. D'Agostino RB, Ramachandran SV, Pencina MJ, et al. General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation 2008; 117: 743-753.
21. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24: 987-1003.
22. Chambless LE, Heiss G, Shahar E, et al. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004; 160: 259-269.
23. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635-1701.
24. Agenzia Italiana del Farmaco. Modifica alla Nota AIFA n.13 09/04/2013. Gazzetta Ufficiale, 9 April 2013, n. 83.
25. Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. Med Decis Making 2008; 8: 53-53.
26. Cavelaars AEJM, Kunst AE, Geurts JJM, et al. Educational differences in smoking: International comparison. Br Med J 2000; 320: 1102-1107.
27. Beer-Borst S, Hercberg S, Morabia A, et al. Dietary pattern in six European populations: Results from EURALIM, a collaborative European data harmonization and information campaign. Eur J Clin Nutr 2000; 54: 253-262.
28. The Research Group of the Project Italian National Register of Coronary and Cerebrovascular Events. Italian national register of major coronary events: Attack rates and fatality in different areas of the country. Ital Heart J Suppl 2005; 6: 667-673.
29. Palmieri L, Barchielli A, Cesana G, et al. Research Group of the Project Italian National Register of Coronary and Cerebrovascular Events. The Italian register of cardiovascular diseases: Attack rates and case fatality for cerebrovascular events. Cerebrovasc Dis 2007; 24: 530-539.
30. Jørgensen T, Jacobsen RK, Toft U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. Br Med J 2014; 348: g3617-g3617.
31. Ketola E, Laatikainen T, Vartiainen E,. Evaluating risk for cardiovascular diseases-vain or value? How do different cardiovascular risk scores act in real life. Eur J Public Health 2010; 20: 107-112.
32. Fornari C, Madotto F, Demaria M, et al. Record-linkage procedures in epidemiology: An Italian multicentre study. Epidemiol Prev 2008; 32: 79-88.
33. Cook NR, Ridker PM,. Response to comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. Circulation. 2014; 129: 268-269.